Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: A prevention study

Diabetologia

Volumn 42, Issue 10, 1999, Pages 1187-1194

  Obrosova, I G ^a   Fathallah, L ^a   Lang, H J ^b   Greene, D A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; IDITOL DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; ENZYME INHIBITION; MALE; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; FRUCTOSE; GLUTATHIONE; L-IDITOL 2-DEHYDROGENASE; MALE; MALONDIALDEHYDE; MITOCHONDRIA; NAD; OXIDATIVE STRESS; PERIPHERAL NERVES; RATS; RATS, WISTAR; SCIATIC NERVE; SPECTROMETRY, FLUORESCENCE;

EID: 0032858197     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051290     Document Type: Article

References (73)

1. Gillon KR, Hawthorne JN, Tomlinson DR (1983) Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition. Diabetologia 25: 365-371
2. Calcutt NA, Mizisin AP, Kalichman MW (1994) Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve. Eur J Pharmacol 251: 27-33
3. Hotta N, Koh N, Sakakibara F et al. (1996) Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor. J Pharmacol Exp Ther 276: 49-55
4. Cameron NE, Cotter MA, Basso M, Hohman TC (1997) Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction, and tissue polyol pathway metabolites in streptozotocindiabetic rats. Diabetologia 40: 271-281
5. Ino-ue M, Yokogawa H, Yamamoto M, Naka H, Kuriyama H (1998) Structural impairments in optic nerve of diabetic rats ameliorated with the aldose reductase inhibitor. Exp Eye Res 66: 397-401
6. Ziegler D, Mayer P, Rathwann W, Gries FA (1991) One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy. Diabetes Res Clin Pract 14: 63-73
7. Hotta N, Sakamoto N, Shigeta Y, Kikkawa R, Goto Y (1996) Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: multicenter study. Diabetic Neuropathy Study Group in Japan. J Diabetes Complications 10: 168-172
8. Pfeifer MA, Schumer MP, Gelber DA (1997) Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes 46 [Suppl 2]: S82-S89
9. Greene DA, Arezzo JCA, Brown MB (1999) Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Neurology (in press)
10. Kinoshita JH, Nishimura C (1988) The involvement of aldose reductase in diabetic complications. Diabetes Metab Rev 4: 323-337
11. Kador PF (1988) The role of aldose reductase in the development of diabetic complications. Med Res Rev 8: 325-352
12. Kuruvilla R, Eichberg J (1998) Depletion of phospholipid arachidonoyl-containing molecular species in a human Schwann cell line grown in elevated glucose and their restoration by an aldose reductase inhibitor. J Neurochem 71: 775-783
13. Fernyhough P, Brewster WJ, Fernandes K, Diemel LT, Tomlinson DR (1998) Stimulation of nerve growth-factor and substance P expression in the iris-trigeminal axis of diabetic rats involvement of oxidative stress and effects of aldose reductase inhibition. Brain Res 802: 247-253
14. Ohi T, Saita K, Furikawa S, Ohta M, Hayashi K, Matsukura S (1998) Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor. Exp Neurol 151: 215-220
15. Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK (1994) Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 37: 449-459
16. Nagamatsu M, Nickander KK, Schmelzer JD et al. (1995) Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18: 1160-1167
17. Cotter MA, Love A, Watt MJ, Cameron NE, Dines KC (1995) Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 38: 1285-1294
18. Sugimoto K, Yagihashi S (1997) Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats. Microvasc Res 53: 105-112
19. Low PA, Nickander KK, Trischler HJ (1997) The Roles of Oxidative Stress and Antioxidant Treatment in Experimental Diabetic Neuropathy. Diabetes 46 [Suppl 2]: S38-S42
20. Cameron NE, Cotter MA (1997) Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 46 [Suppl 2]: S31-S37
21. Greene DA, Lattimer S, Ulbrecht J, Carroll P (1985) Glucose-induced alterations in nerve metabolism: Current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care 8: 290-299
22. Zhu X, Eichberg J (1993) Molecular species composition of glycerolipids in rat sciatic nerve and its alteration in streptozotocin-induced diabetes. Biochim Biophys Acta 1168: 1-12
23. Sozuki E, Yasuda K, Yasuda K et al. (1994) 1H-NMR analysis of nerve edema in the streptozotocin-induced diabetic rat. J Lab Clin Med 124: 627-637
24. Doss DJ, Kuruvilla R, Bianchi R, Peterson RG, Eichberg J (1997) Effects of hypoxia and severity of diabetes on Na, KATPase activity and arachidonoyl-containing molecular species in streptozotocin-diabetic rat nerve. J Peripheral Nerv Syst 2: 1-9
25. Mizisin AP, Bache M, DiStefano PS, Acheson A, Lindsay RM, Calcutt NA (1997) BDNF attenuates functional and structural disorders in nerves of galactose-fed rats. J Neuropath Exp Neurol 56: 1290-1301
26. Hounsom L, Horrobin DF, Tritschler H, Corder R, Tomlinson DR (1998) A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy. Diabetologia 41: 839-844
27. Apfel SC, Kessler JA, Adornato BT, Litchy WJ, Sanders C, Rask CA (1998) Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology 51: 695-702
28. Williamson JR, Chang K, Frangos M et al. (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801-813
29. Tilton RG, Chang K, Neyengaard JR, van den Enden M, Ido Y, Williamson JR (1995) Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozotocin-induced diabetic rats. Diabetes 44: 234-242
30. Geissen K, Utz R, Grotsch H, Lang J, Nimmesgern H (1994) Sorbitol-accumulating Pyrimidine Derivatives. Arzneimittelforschung 44: 1032-1043
31. Oates P, Schelhorn T, Miller M et al. (1998) Polyol pathway inhibitors dose-dependently preserve nerve function in diabetic rats. Diabetologia 41 [Suppl 1]: A271 (Abstract)
32. Ng DT, Lee FK, Song ZT et al. (1998) Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. Diabetes 47: 961-966
33. Delcroix JD, Michael GJ, Priestley JV, Tomlinson DR, Fernyhough P (1998) Effect of nerve growth factor treatment on p75NTR gene expression in lumbar dorsal root ganglia of streptozotocin-induced diabetic rats. Diabetes 47: 1779-1785
34. Obrosova I, Kuchmerovskaya T, Parkhomets P, Klimenko A, Yefimov A (1994) Serotonin and GABA uptake and release by brain cortex synaptosomes of streptozotocin-diabetic and galactosemic rats: effect of aldose reductase inhibitor. Diabetologia Croatica 23: 63-70
35. Ralevie V, Belai A, Burnstock G (1995) Effects of streptozotocin-diabetes on sympathetic nerve, endothelial and smooth muscle function in the rat mesenteric arterial bed. Eur J Pharmacol 286: 193-199
36. Kamei J, Ohsawa M (1996) Effects of diabetes on methamphetamine-induced preference in mice. Eur J Pharmacol 318: 251-256
37. Mizisin AP, Shelton GD, Wagner S, Rusbridge C, Powell HC (1998) Myelin splitting, Schwann cell injury and demyelination in feline diabetic neuropathy. Acta Neuropathol (Berl) 95: 171-174
38. Kalichman MW, Powell HC, Mizisin AP (1998) Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol (Berl) 95: 47-56
39. Chokroverty S, Selden D, Navidad P, Cody R (1988) Distal axonopathy in streptozotocin diabetes in rats. Experientia 44: 444-446
40. Fernyhough P, Gallagher A, Averill SA et al. (1999) Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes 48: 881-889
41. Schmidt RE, Dorsey DA, Beaudet LN, Plurad SB, Williamson JR, Ido Y (1998) Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy. J Neuropath Exp Neurol 57: 1175-1189
42. Low PA, Ward K, Schmelzer JD, Brimijoin S (1985) Ischemic conduction failure and energy metabolism in experimental diabetic neuropathy. Am J Physiol 248: E457-E462
43. Low PA, Schmelzer JD, Ward KK, Curran GL, Poduslo JF (1988) Effect of hyperbaric oxygenation on normal and chronic streptozotocin diabetic peripheral nerves. Exp Neurol 99: 201-212
44. Greene DA, Cao X, Van Huysen C, Obrosova IG (1998) Effects of DL-α-lipoic acid (LA) on diabetic nerve function, bioenergetics, and antioxidative defense. Diabetes 47 [Suppl 1]: A136 (Abstract)
45. Bravenboer B, Kappelle AC, Hamers FP, van Buren T, Erkelens DW, Gispen WH (1992) Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia 35: 813-814
46. Obrosova I, Cao X, Greene DA, Stevens MJ (1998) Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: effect of DL-α-lipoic acid. Diabetologia 41: 1442-1450
47. Obrosova IG, Stevens MJ (1999) Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens. Invest Ophthalmol Vis Sci 40: 680-688
48. Erdelmeier I, Gerard-Monnier D, Yadan JC, Chaudiere J (1998) Reactions of N-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Mechanistic aspects of the colorimetric assay of lipid peroxidation. Chem Res Toxicol 11: 1184-1194
49. Lowry OH, Passoneau TV (1972) A Flexible System of Enzymatic Analysis. Academic Press, Orlando
50. Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74: 214-226
51. Williamson DH, Lund P, Krebs HA (1967) The Redox State of Free Nicotinamide-Adenine Dinucleotide in the Cytoplasm and Mitochondria of Rat Liver. Biochem J 103: 514-527
52. Veech RL, Eggleston LV, Krebs HA (1969) The Redox State of Free Nicotinamide-Adenine Nucleotide Phosphate in the Cytoplasm of Rat Liver. Biochem J 115: 609-619
53. Masuda T, Dobson GP, Veech RL (1990) The Gibbs-Donnan Near-equilibrium System of Heart. J Blot Chem 265: 20321-20334
54. Tuck RR, Schmelzer JD, Low PA (1984) Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107: 935-950
55. Hotta N, Koh N, Sakakibara F et al. (1996) Effects of beraprost sodium and insulin on the lectroretinogram, nerve conduction, and nerve blood flow in rats with streptozotocin-induced diabetes. Diabetes 45: 361-366
56. Dewhurst M, Omawari N, Tomlinson DR (1997) Aminoguanidine - effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control anbd streptozotocin-diabetic rats. Br J Pharmacol 120: 593-598
57. Calcutt NA, Dines KC, Cesena RM (1998) Effects of the peptide HP228 on nerve disorders in diabetic rats. Metabolism 47: 650-656
58. Kalichman MW, Dines KC, Bobik M, Mizisin AP (1998) Nerve conduction velocity, laser Doppler flow, and axonal caliber in galactose and streptozotocin diabetes. Brain Res 810: 130-137
59. Sasaki H, Schmelzer ID, Zollman PJ, Low PA (1997) Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats. Acta Neuropathol (Berl) 93: 118-128
60. Hassinen IE, Hiltunen K (1975) Respiratory control in isolated perfused rat heart. Role of the equilibrium reactions between the mitochondrial electron carriers and the adenylate system. Biochim Biophys Acta 408: 319-330
61. Low PA, Schmelzer JD, Ward KK, Yao JK (1986) Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy. Am g Physiol 250: E94-E99
62. Greene DA, Lattimer SA (1984) Impaired energy utilization and Na-K-ATP-ase in diabetic peripheral nerve. Am J Physiol 246: E311-E318
63. Ogawa S, Lee TM, Glynn P (1986) Energy metabolism in rat brain in vivo studied by 31P nuclear magnetic resonance: changes during postnatal development. Arch Biochem Biophys 248: 43-52
64. Low PA, Yao JK, Kishi Y et al. (1997) Peripheral nerve energy metabolism in experimental diabetic neuropathy. Neurosci Res Commun 21: 49-56
65. Cameron NE, Cotter MA, Horrobin DH, Tritschler HJ (1998) Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids. Diabetologia 41: 390-399
66. Cheng HM, Hirose K, Xiong H, Gonzalez RG (1989) Polyol pathway activity in streptozotocin-diabetic rats lens. Exp Eye Res 49: 87-92
67. Mehta A, Jarori GK, Kenkare UW (1988) Brain hexokinase has no pre-existing allosteric site for glucose 6-phosphate. J Biol Chem 263: 15492-15497
68. Vicario C, Arizmendi C, Malloch G, Clark JB, Medina JM (1991) Lactate utilization by isolated cells from early neonatal rat brain. J Neurochem 57: 1700-1707
69. Greene DA, Winegrad AI (1981) Effects of acute experimental diabetes on composite energy metabolism in peripheral nerve axons and Schwann cells. Diabetes 30: 967-974
70. Poulsom R, Mirrlees DJ, Earl DC, Heath H (1983) The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic rats. Exp Eye Res 36: 751-760
71. Cameron NE, Cotter MA, Dines KC, Hohman TC (1996) Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121, 509, in streptozotocin-induced diabetic rats. J Diabetes Complications 10: 43-53
72. Lehninger AL (1987) Principles of Biochemistry. Worth Publishers Inc., New York
73. Van Dam PS, Van Asbeck BS, Bravenboer B, Van Oirschot JF, Gispen WH, Marx JJ (1998) Nerve function and oxidative stress in diabetic and vitamin E-deficient rats. Free Radic Biol Med 24: 18-26